Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Gail Model Underestimates Breast Cancer Risk in Thai Population.

Sa-Nguanraksa D, Sasanakietkul T, O-Charoenrat C, Kulprom A, O-Charoenrat P.

Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2385-2389. doi: 10.31557/APJCP.2019.20.8.2385.

2.

Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.

Sa-Nguanraksa D, O-Charoenrat E, Kulprom A, Samarnthai N, Lohsiriwat V, Nimpoonsri K, O-Charoenrat P.

Breast Cancer. 2019 Jul;26(4):471-477. doi: 10.1007/s12282-019-00945-8. Epub 2019 Jan 7.

PMID:
30617675
3.

High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis.

Amornsupak K, Jamjuntra P, Warnnissorn M, O-Charoenrat P, Sa-Nguanraksa D, Thuwajit P, Eccles SA, Thuwajit C.

Clin Breast Cancer. 2017 Oct;17(6):441-452.e2. doi: 10.1016/j.clbc.2017.04.007. Epub 2017 Apr 21.

4.

Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.

Sa-Nguanraksa D, Suntiparpluacha M, Kulprom A, Kummalue T, Chuangsuwanich T, Avirutnan P, O-Charoenrat P.

Asian Pac J Cancer Prev. 2016;17(6):2935-40.

5.

High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer.

Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P.

Mol Clin Oncol. 2015 Sep;3(5):1103-1108. Epub 2015 Jun 9.

6.

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.

Amornsupak K, Insawang T, Thuwajit P, O-Charoenrat P, Eccles SA, Thuwajit C.

BMC Cancer. 2014 Dec 15;14:955. doi: 10.1186/1471-2407-14-955.

7.

Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.

Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P, Komoltri C, Watcharahirun S, Sa-Nguanraksa D.

Asian Pac J Cancer Prev. 2014;15(3):1187-92.

8.

Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer.

Sa-Nguanraksa D, Kooptiwut S, Chuangsuwanich T, Pongpruttipan T, Malasit P, O-Charoenrat P.

Mol Med Rep. 2014 Mar;9(3):1044-8. doi: 10.3892/mmr.2014.1890. Epub 2014 Jan 9.

PMID:
24401996
9.

Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.

Sa-Nguanraksa D, Chuangsuwanich T, Pongpruttipan T, Kummalue T, Rojananin S, Ratanawichhitrasin A, Prasarttong-Osoth P, Chuthatisith S, Pisarnturakit P, Aeumrithaicharoenchok W, Rushatamukayanunt P, Lohsiriwat V, Boonsripitayanon M, Malasit P, O-Charoenrat P.

Mol Med Rep. 2013 Oct;8(4):1242-50. doi: 10.3892/mmr.2013.1607. Epub 2013 Jul 31.

PMID:
23904001
10.

A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer.

Ithimakin S, Ratanawichitrasin A, Veerasarn V, Akewanlop C, Soparattanapaisarn N, Rojananin S, O-Charoenrat P, Prasarttong-Osoth P, Srimuninnimit V.

J Med Assoc Thai. 2013 Feb;96 Suppl 2:S67-74.

PMID:
23590024
11.

The role of vascular endothelial growth factor a polymorphisms in breast cancer.

Sa-Nguanraksa D, O-Charoenrat P.

Int J Mol Sci. 2012 Nov 13;13(11):14845-64. doi: 10.3390/ijms131114845. Review.

12.

Association of glutathione S-transferase omega gene polymorphisms with progression of head and neck cancer.

Sanguansin S, Petmitr S, O-Charoenrat P, Pongstaporn W.

Mol Biol Rep. 2012 Dec;39(12):10915-20. doi: 10.1007/s11033-012-1991-3. Epub 2012 Oct 20.

PMID:
23086268
13.

The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.

Pongsavee M, Yamkamon V, Dakeng S, O-charoenrat P, Smith DR, Saunders GF, Patmasiriwat P.

Genet Test Mol Biomarkers. 2009 Jun;13(3):307-17. doi: 10.1089/gtmb.2008.0127.

PMID:
19405875
14.

Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis.

Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B.

BMC Cancer. 2009 Jan 12;9:11. doi: 10.1186/1471-2407-9-11.

15.

SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2.

O-charoenrat P, Sarkaria I, Talbot SG, Reddy P, Dao S, Ngai I, Shaha A, Kraus D, Shah J, Rusch V, Ramanathan Y, Singh B.

Clin Cancer Res. 2008 Nov 1;14(21):6780-9. doi: 10.1158/1078-0432.CCR-08-0719.

16.

Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.

Luangdilok S, Box C, Patterson L, Court W, Harrington K, Pitkin L, Rhŷs-Evans P, O-charoenrat P, Eccles S.

Cancer Res. 2007 Aug 15;67(16):7907-16.

17.

Antiproliferative effect of Erycibe elliptilimba on human breast cancer cell lines.

Kummalue T, O-charoenrat P, Jiratchariyakul W, Chanchai M, Pattanapanyasat K, Sukapirom K, Iemsri S.

J Ethnopharmacol. 2007 Apr 4;110(3):439-43. Epub 2006 Oct 28.

PMID:
17140753
18.

Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas.

Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, Kaufman A, Ryan R, Ghossein R, Rao PH, Stoffel A, Ramanathan Y, Singh B.

Cancer Res. 2006 Oct 1;66(19):9437-44.

19.
20.
21.

Enhanced nectin-1 expression and herpes oncolytic sensitivity in highly migratory and invasive carcinoma.

Yu Z, Chan MK, O-charoenrat P, Eisenberg DP, Shah JP, Singh B, Fong Y, Wong RJ.

Clin Cancer Res. 2005 Jul 1;11(13):4889-97.

22.

Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung.

Talbot SG, Estilo C, Maghami E, Sarkaria IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein R, Viale A, Park BJ, Rusch VW, Singh B.

Cancer Res. 2005 Apr 15;65(8):3063-71.

23.

Biological significance of c-erbB family oncogenes in head and neck cancer.

Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA.

Cancer Metastasis Rev. 2005 Jan;24(1):47-69. Review.

PMID:
15785872
24.

Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.

O-charoenrat P, Rusch V, Talbot SG, Sarkaria I, Viale A, Socci N, Ngai I, Rao P, Singh B.

Clin Cancer Res. 2004 Sep 1;10(17):5792-803.

25.

Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells.

O-charoenrat P, Wongkajornsilp A, Rhys-Evans PH, Eccles SA.

Int J Cancer. 2004 Aug 20;111(2):174-83.

26.

Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.

Talbot SG, O-charoenrat P, Sarkaria IS, Ghossein R, Reddy P, Ngai I, Cordeiro CN, Wong RJ, Kris MG, Rusch VW, Singh B.

Ann Surg Oncol. 2004 May;11(5):530-4.

PMID:
15123463
27.

The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.

Estilo CL, O-Charoenrat P, Ngai I, Patel SG, Reddy PG, Dao S, Shaha AR, Kraus DH, Boyle JO, Wong RJ, Pfister DG, Huryn JM, Zlotolow IM, Shah JP, Singh B.

Clin Cancer Res. 2003 Jun;9(6):2300-6.

28.

Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer.

O-charoenrat P, Pillai G, Patel S, Fisher C, Archer D, Eccles S, Rhys-Evans P.

Oral Oncol. 2003 Jun;39(4):386-90.

PMID:
12676259
29.

The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma.

O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA.

Oral Oncol. 2002 Oct;38(7):627-40. Review.

PMID:
12167415
31.

p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.

Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I, Chou TC, O-Charoenrat P, Levine AJ, Rao PH, Stoffel A.

Genes Dev. 2002 Apr 15;16(8):984-93.

33.
34.
35.

Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

O-Charoenrat P, Rhys-Evans PH, Eccles SA.

Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20.

PMID:
11448356
36.

Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells.

O-charoenrat P, Rhys-Evans P, Modjtahedi H, Eccles SA.

Clin Exp Metastasis. 2000;18(2):155-61.

PMID:
11235991
37.

Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells.

O-Charoenrat P, Rhys-Evans P, Eccles S.

Int J Cancer. 2000 Dec 1;88(5):759-65.

38.
39.
40.

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA.

Cancer Res. 2000 Feb 15;60(4):1121-8.

Supplemental Content

Loading ...
Support Center